Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.0230
-0.0040 (-14.81%)
At close: Jul 20, 2026
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $1.43 million as of July 20, 2026. Its market cap has decreased by -96.32% in one year.
Market Cap
1.43M
Enterprise Value
24.16M
Revenue
390.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
ChartMarket Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from 179.38M to 1.43M, a decrease of -99.20%. That is a compound annual growth rate of -44.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.43M | -91.94% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| America Great Health | 2.12M |
| Bio-Path Holdings | 1.91M |
| Hepion Pharmaceuticals | 1.78M |
| Innovation Pharmaceuticals | 1.59M |
| International Stem Cell | 1.44M |
| AXIM Biotechnologies | 1.34M |
| Neon Bloom | 1.33M |
| inTerra Resources | 1.30M |